|
Mechanism50S subunit inhibitors [+2] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date25 Jun 1958 |
100 Clinical Results associated with PBP3 x GR x 50S subunit
100 Translational Medicine associated with PBP3 x GR x 50S subunit
0 Patents (Medical) associated with PBP3 x GR x 50S subunit